百利天恒(688506.SH)子公司收到与百时美施贵宝就iza-bren项目里程碑付款2.5亿美元

Core Viewpoint - SystImmune, a wholly-owned subsidiary of Baillie Gifford (688506.SH), has received a milestone payment of $250 million from BMS, with potential for additional payments totaling up to $2.5 billion in the near term and up to $7.1 billion in further payments upon achieving specific development, registration, and sales milestones [1] Group 1 - The company has received a milestone payment of $250 million from BMS [1] - The collaboration agreement allows for additional payments of up to $2.5 billion based on future milestones [1] - There is potential for further payments totaling up to $7.1 billion upon reaching specific development, registration, and sales milestones [1]